Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Illinois Valley Hospital
mi
from
Peru, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Illinois Valley Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Valley Radiation Oncology
mi
from
Peru, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Valley Radiation Oncology
mi
from
Peru, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Perry Memorial Hospital
mi
from
Princeton, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Perry Memorial Hospital
mi
from
Princeton, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Sarah Culbertson Memorial Hospital
mi
from
Rushville, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Sarah Culbertson Memorial Hospital
mi
from
Rushville, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Margaret's Hospital
mi
from
Spring Valley, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Margaret's Hospital
mi
from
Spring Valley, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Carle Cancer Center
mi
from
Urbana, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Carle Clinic-Urbana Main
mi
from
Urbana, IL
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Carle Clinic-Urbana Main
mi
from
Urbana, IL
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Franciscan Saint Anthony Health-Michigan City
mi
from
Michigan City, IN
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Franciscan Saint Anthony Health-Michigan City
mi
from
Michigan City, IN
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
McFarland Clinic PC-William R Bliss Cancer Center
mi
from
Ames, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
McFarland Clinic PC-William R Bliss Cancer Center
mi
from
Ames, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Constantinou, Costas L MD
mi
from
Bettendorf, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Constantinou, Costas L MD
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Anthony Regional Hospital
mi
from
Carroll, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Anthony Regional Hospital
mi
from
Carroll, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Hospital
mi
from
Cedar Rapids, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Hospital
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Cedar Rapids Oncology Association
mi
from
Cedar Rapids, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Cedar Rapids Oncology Association
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital
mi
from
Cedar Rapids, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Oncology Associates at Mercy Medical Center
mi
from
Cedar Rapids, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Oncology Associates at Mercy Medical Center
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Alegent Health Mercy Hospital
mi
from
Council Bluffs, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Alegent Health Mercy Hospital
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Mercy Capitol
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Mercy Capitol
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Iowa Methodist Medical Center
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Iowa Oncology Research Association CCOP
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Iowa Oncology Research Association CCOP
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-Des Moines
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Community Memorial Hospital
mi
from
Missouri Valley, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Community Memorial Hospital
mi
from
Missouri Valley, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Burgess Memorial Hospital
mi
from
Onawa, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Burgess Memorial Hospital
mi
from
Onawa, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Siouxland Regional Cancer Center
mi
from
Sioux City, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Siouxland Regional Cancer Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Regional Medical Center
mi
from
Sioux City, IA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Hospital District Sixth of Harper County
mi
from
Anthony, KA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Hospital District Sixth of Harper County
mi
from
Anthony, KA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital of Arkansas City
mi
from
Arkansas City, KA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital of Arkansas City
mi
from
Arkansas City, KA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Southwest Medical Center
mi
from
Liberal, KA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Southwest Medical Center
mi
from
Liberal, KA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas - Ottawa
mi
from
Ottawa, KA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas - Ottawa
mi
from
Ottawa, KA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas - Main Office
mi
from
Wichita, KA
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas - Main Office
mi
from
Wichita, KA
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Bixby Medical Center
mi
from
Adrian, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Hickman Cancer Center
mi
from
Adrian, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Hickman Cancer Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Michigan Cancer Research Consortium CCOP
mi
from
Ann Arbor, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Michigan Cancer Research Consortium CCOP
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Oakwood Hospital and Medical Center
mi
from
Dearborn, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Oakwood Hospital and Medical Center
mi
from
Dearborn, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint John Hospital and Medical Center
mi
from
Detroit, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint John Hospital and Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Genesys Regional Medical Center-West Flint Campus
mi
from
Flint, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Genesys Regional Medical Center-West Flint Campus
mi
from
Flint, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Allegiance Health
mi
from
Jackson, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Center for Hematology- Oncology of Southern Michigan PLC
mi
from
Jackson, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Center for Hematology- Oncology of Southern Michigan PLC
mi
from
Jackson, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Mercy Memorial Hospital
mi
from
Monroe, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Mercy Memorial Hospital
mi
from
Monroe, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Toledo Clinic Cancer Centers - Monroe
mi
from
Monroe, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Toledo Clinic Cancer Centers - Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Mercy Port Huron
mi
from
Port Huron, MI
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Mercy Port Huron
mi
from
Port Huron, MI
Click here to add this to my saved trials